Lymphocytes activated by antigens or mitogens acquire the capacity to replicate viruses, and the number of activated lymphocytes can be estimated by the virus plaque assay. Concanavalin A and pokeweed mitogen produced 33-fold and 17-fold increases in virus plaqueforming cells (V-PFC), respectively, above background, while lipopolysaccharide produced only a 2-to 3-fold increase. T (thymus-derived lymphocyte)-depleted lymphocyte populations, derived from anti-O-treated or nude (athymic) mouse spleens, failed to produce V-PFC after culture with concanavalin A or pokeweed mitogen. The present studies thus demonstrate that the virus plaque assay measures activated T-lymphocytes.
In the present studies, while stimulation of CBA (H2k) lymphocytes by DBA/2 (H2d) cells produced high levels of thymidine incorporation, lymphocyte target-cell cytotoxicity, and V-PFC, stimulation of BALB/c (H2d) lymphocytes against DBA/2 (H2d) cells resulted in even higher levels of thymidine incorporation with a virtual absence of cytotoxic lymphocytes or V-PFC. These results indicate that proliferation is not a sufficient condition for permitting lymphocytes either to exert cytotoxicity on target cells or to replicate viruses, and suggest that there may be a correlation between the development of V-PFC and cytotoxic lymphocytes. They are consistent with the view that there are at least two functional subpopulations of T-lymphocytes.
Thymus-derived lymphocytes (T-cells) play a major role in cell-mediated immune responses such as delayed type hypersensitivity, allograft rejection, tumor immunity, and cellular resistance to infection (1) . In addition they serve as helper cells in the production of antibodies to thymus-dependent antigens (2) . The nature of T-cell function has been elucidated by in vitro studies of T-lymphocyte activation (3, 4) , development of T-lymphocyte cytotoxicity (5, 6) , and production of various products of activated lymphocytes or mediators (4, 7) . However, the principal obstacle to a more complete understanding of the cell-mediated immune response has been the lack of a simple, general, and reproducible method for enumerating activated T-lymphocytes, analogous to the Jerne plaque assay for antibody-producing cells.
Abbreviations: V-PFC, virus plaque-forming cell; Con A, concanavalin A; PHA, phytohemagglutinin; PWM, pokeweed mitogen; LPS, lipopolysaccharide; VSV, vesicular stomatitis virus, T and B, thymus-and bone-marrow-derived (lymphocytes), respectively.
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A virus plaque assay has been developed as a method for enumerating antigen-and mitogen-activated lymphoid cells (8, 9) . The assay is based on the earlier observation that while unstimulated small lymphocytes do not support the replication of RNA viruses, antigen-or mitogen-stimulated lymphocytes rapidly acquired the capacity to do so (see ref. 8) . The enhancement of virus production in culture is due to an increase in the number of lymphocytes replicating virus, and increased virus plaque-forming cells (V-PFC) have been observed in cultures of antigen-stimulated lymphocytes obtained from delayed hypersensitive human (10) and guinea pig donors (8) and in mixed lymphocyte cultures (11) . The rate of increase in V-PFC in cultures stimulated with purified tuberculin (PPD) was linear over a 4-day culture period and unaffected by the mitotic inhibitor, vinblastine (10) . This finding suggested the existence of a nondividing, antigensensitive cell, in contrast to the exponentially proliferating blasts cells in the same cultures.
The purpose of the present study is 2-fold: first, to clarify the nature of the virus plaque-forming cell, i.e., whether activated T-or B-lymphocytes or both are detected by the virus plaque assay; and second, to investigate the relationship of the V-PFC to the proliferating cells in mixed lymphocyte cultures and to the cytotoxic lymphocytes derived from them. The basic experimental design was to explore the enhancement of production of V-PFC in mouse spleens by mitogens that selectively stimulate T-lymphocytes (concanavalin A and phytohemagglutinin), B (bone-marrow-derived)-lymphocytes (lipopolysaccharide), and both T-and B-lymphocytes (pokeweed mitogen).
MATERIALS AND METHODS
Animals. Female C57B1/10, CBA, DBA/2, and BALB/c mice were obtained from Jackson Laboratories, Bar Harbor, Me., and were used at 6-12 weeks of age. Congenitally athymic (nude) mice (nu/nu) were used at 3.5 weeks of age.
Cell Suspensions and Cultures. Spleens were removed aseptically. Dissociated cells were washed twice, suspended in medium RPMI 1640 supplemented with 5% heat-inactivated fetal-calf serum (Reheis Chemical Co., Chicago, Ill., lot no. 72208), 2 mM -glutamine, and 100 units of penicillin and 100 Ag of streptomycin per ml, and adjusted to 15 with vesicular stomatitis virus (VSV) at a multiplicity of infection, for these experiments, of 100 for 2 hr at 37°. After infection cells were washed once and treated with 0.02 ml of guinea pig anti-VSV serum for 1 hr at 40 to neutralize free virus. After three washings, aliquots of suspensions of virusinfected cells were plated in a thin layer of agar on a monolayer of indicator b-cells in 60-mm plastic culture dishes. Three log dilutions of each sample were plated; each was done in duplicate. The plates were incubated for 2 days at 370 in 5% CO2 in air, and the virus plaques were counted after they were stained with neutral red. Assays of Thymidine Inrcorporation and Lymphocyte Cytotoxicity.
Isoantiserumm and
[8H]Thymidine (2 pCi, specific activity 6.0 Ci/mmol) was added for a 24-hr period to assess DNA synthesis, and labeled cells were harvested at days 3 and 4. Lymphocyte cytotoxicity was assayed on day 4 by the method described by Cerottini and Brunner (15) at a lymphocyte: target cell ratio of 60:1. 5'Cr-release was assayed at 5 hr.
RESULTS
An increase in virus plaque-forming cells above the background (AV-PFC) in cultures stimulated by Con A, PWM, or LPS is clearly observed by the first day, reaching maximum usually on the second day of stimulation, and declining thereafter. In contrast, DNA synthesis in response to these mitogens, while high at 48 hr, generally increased slightly at 72 hr. The magnitude of the virus plaque-forming cell response to optimal doses of Con A, PWM, and LPS was compared on the second day of stimulation (Fig. 1 lation by Con A produced a 33-fold increase in virus plaqueforming cells above background, PWM produced a 17-fold increase, and LPS produced a slight though statistically significant increase, about 2-3 times background. The AV-PFC response to the B-cell mitogen LPS represented only 3.6% of that produced by Con A or 7.0% of that produced by PWM in the same spleen cultures.
In order to assess the contribution of T-and B-lymphocytes to the production of V-PFC, two types of T-depleted lymphocyte populations were studied. First, anti-C serum (AKR anti-OC3H) and complement-treated spleen cells were stimulated by Con A, PWM, and LPS and compared with spleen cells treated with normal-mouse serum plus complement. A 99% diminution in the specific virus plaque-forming cells inducible by Con A or PWM was observed in three experiments in the anti-C-treated spleens ( Table 1) . The conditions for anti-C treatment were selected such that 90% of C57B1/10 thymocytes were killed but no diminution in Jerne PFC to sheep erythrocytes was observed. Second, culturing congenitally athymic (nude) mouse spleens with Con A in two experiments failed to stimulate an increase in V-PFC, whereas 16,000 V-PFC/106 cells were induced in control spleens (Table  1) . PWM induced as many V-PFCs as Con A in control spleens, but only a marginal increase in V-PFC in nude mouse spleen. LPS produced small responses of comparable magnitude in both nude and control spleens.
It is thus clear that the virus plaque assay is thymus-dependent, but it is not yet formally demonstrated that V-PFCs are indeed T-cells. However, stimulation of thymocytes, a population containing fewer than 1% B-cells, with Con A produced about 3% V-PFC on day 2. Additionally, Con Astimulated spleen cells were treated with anti-C serum and guinea pig complement on day 1 of stimulation, and, while 20-30% of the cells were killed, a 70-80% diminution in V-PFC was obtained. However, the same anti-C treatment failed to diminish significantly the Con A-stimulated V-PFC on day 2 and killed only 2% of the cells, consistent with the finding that activated lymphocytes are more resistant to immune cytolysis by anti-C (16) . When a 4-fold increased concentration of anti-C serum was used with absorbed rabbit complement, 65% of the Con A-stimulated cells could be killed on day 2; V-PFC were reduced in this case by more than 99% (Table 2A) . To rule out nonspecific effects with high doses of the AKR anti-C serum, these results were confirmed by use of a sample of congenic (C/AKRb --ASL,)
anti-C serum (Table 2B ). Together, these experiments demonstrate that virtually all V-PFC after Con A stimulation are, in fact, 0-positive T-lymphocytes.
Although the stimulation by LPS was invariably less than 10% of that produced by Con A or PWM, it was of interest to explore the nature of the V-PFC in this case. Because the degree of stimulation of LPS for V-PFC was much less than for thymidine incorporation, only a subpopulation of activated B-lymphocytes could be involved. One such subpopulation, the plasma cells, have been distinguished by the PC.1 alloantigen on their surface (17) . When LPS-stimulated cultures of BALB/c spleens were treated with anti-PC.1 serum plus complement in three experiments, the number of V-PFC was diminished between 40 and 70% (Table 2C ). The same conditions of anti-PC.1 treatment killed 85-90% of PC.1 (+) BALB/c myeloma MPC-11 and fewer than 5% of BALB/c thymocytes. This result suggests that the slight increase in V-PFC induced by LPS is largely attributable to plasma cells that are differentiated sufficiently to contain the PC. 1 antigen and to replicate viruses.
In previous work (10) , evidence was presented that indicates a dissociation of cell proliferation and the V-PFC response in antigen-induced activation of lymphocytes from delayed hypersensitive donors and in mitogen-induced activation of lymphocytes. Recently, a striking dissociation between the proliferative response and development of cytotoxic lymphocytes in the mixed lymphocyte culture system has been observed (36) . BALB/c (H2d) lymphocytes can be stimulated in mixed lymphocyte cultures to incorporate thymidine by mitomycin-treated DBA/2 (H2d) cells that are identical at the major histocompatibility locus (18, 19) . Such activated BALB/c lymphocytes are, however, incapable of lysing 51Cr-labeled DBA/2 mastocytoma target cells or Con A-stimulated DBA/2 spleen cells in vitro. In contrast, CBA lymphocytes (H2k) stimulated by DBA/2 (H2d) cells both proliferate and differentiate into cytotoxic lymphocytes. When the virus plaque assay was performed on these two combinations of mixed lymphocyte cultures, a marked increase in V-PFC was observed in only one combination (Table 3) . CBA lymphocytes stimulated by DBA/2 cells exhibited proliferation, target cell killing, and virus plaque-forming cells, while the BALB/c against DBA/2 combination, which incorporated equal or greater amounts of thymidine, failed to lyse DBA/2 target cells or produce virus. It should be noted that the mixed lymphocyte culture stimulation in both combinations is abolished by treatment with anti-B serum (36) . Although only two combinations of mixed lymphocyte cultures have been studied here, these experiments demonstrate that proliferation is not a sufficient condition for permitting lymphocytes either to exert direct cytotoxicity on target cells or to replicate viruses, and suggest that there may be a correlation between the development of V-PFC and cytotoxic lymphocytes.
DISCUSSION
While the Jerne plaque assay, which permits enumeration of antibody-producing cells to certain antigens, has permitted a clearer understanding of the development of antibodyproducing cells, the inability to enumerate antigen-sensitive T-lymphocytes has remained a major handicap to the understanding of cellular immunology.
A virus plaque assay was introduced in an attempt to deal with this problem (8, 9) . It is based on the observation that small lymphocytes are incapable of replicating various viruses, but when stimulated with mitogens or antigens, they become capable of doing so. By estimating the number of lymphocytes activated to produce virus by means of an infectious centers assay, the enhancement of virus replication was shown to be due to an increase in the number of virusproducing cells. Previous studies with this assay had indicated (i) increases in V-PFC were observed when cells obtained from delayed-hypersensitive donors were stimulated with specific antigens (8), (ii) at the electron microscopic level the virusproducing cell was an enlarged small lymphocyte (20), (iii) the absolute efficiency of the virus plaque assay for murine 0 (+) lymphomas after a 2-hr infection with VSV was about 60%, and (iv) the kinetics of activation of antigen-sensitive cells by antigen was linear over a 4-day period and not affected by mitotic inhibitors (10) . It was proposed that the virus plaque assay detects nondividing antigen-sensitive cells, characteristic of differentiated effector cells in cell-mediated immunity (4), similar to cells producing the migration inhibitory factor (21, 22 ) and target-cell destruction (23) .
The observed increases in virus plaque-forming cells in delayed type hypersensitivity and mixed lymphocyte cultures suggested that the virus plaque assay selectively detects activated T-lymphocytes. The present work was designed to examine critically that possibility. It has been established that Con A and PHA in mice selectively activate T-lymphocytes (24) (25) (26) , while LPS activates only B-lymphocytes (26, 27) , and PWM probably activates both T-and B-lymphocytes (25) . In the present studies, when normal mouse spleen cells containing both T-and B-lymphocytes were stimulated by these mitogens, a marked increase in V-PFC was obtained with Con A (6%o of the cells) and PWM (3% of the cells), but only a marginal increase with LPS (0.2%) (Fig. 1) . That the virus plaque-forming cells were indeed activated T-lymphocytes was demonstrated by several experiments. When T-lymphocyte-deprived populations, i.e., nude or normal mouse spleen cells treated with anti-B serum and complement were stimulated with the T-cell mitogens, Con A and PWM, little or no increase in V-PFC was obtained (Table 1 ). This observation established that T-lymphocytes were required for the production of V-PFC. Second, mouse thymocytes, thought to contain fewer than 1% B-lymphocytes, could be stimulated by Con A to produce as many as strated that V-PFC obtained even 24 or 48 hr after stimulation by Con A could be eliminated by treatment with anti-B serum. However, higher concentrations of anti-B serum together with absorbed rabbit complement were required for complete abolition of V-PFC by Con A-treated cells after 2 days of stimulation, but the specificity of this effect was confirmed by use of a congenic anti-B (0/AKRb anti ASL1) serum (Table 2 ). These experiments demonstrate unambiguously that the V-PFC in Con A-stimulated mouse spleens are in fact activated T-lymphocytes.
While never greater than 10% of the response to Con A, the small V-PFC response in LPS-stimulated cultures requires some comment. LPS and PWM produced a similar degree of thymidine incorporation, and yet the V-PFC responses differed widely. The equal thymidine incorporation suggests that poor survival of B-lymphocytes in culture cannot explain this disparity. The small increase in V-PFC in activated Blymphocytes could be due either to a very low efficiency of virus replication in activated B-lymphocytes or to replication of virus in a small subpopulation of activated B-lymphocytes. The latter possibility was suggested by two previous observations: an IgM-producing murine plasmacytoma, MOPO-104, was found to replicate VSV, and, at the electromicroscopic level, the few LPS-stimulated lymphocytes associated with virus had dilated rough-surfaced endoplasmic reticulum characteristic of plasma cells (20) . Use of a specific isoantiserum to a cell membrane-associated differentiation antigen, PC.1, plus complement in the present experiments markedly diminished the LPS-induced V-PFC (Table 2) , thus demonstrating that many of these V-PFC are differentiated, PC.1-positive plasma cells. In addition, macrophages represent a major portion of the background V-PFC in unstimulated cultures and may also be activated by LPS to produce virus. In the practical sense, the contribution of the non-T-cell V-PFC represented less than 10% that of activated T-lymphocytes in spleen, and would be even further diminished by use of cell sources containing fewer B-lymphocytes and macrophages, e.g., peripheral blood or lymph nodes, or treated with immunoadsorbants.
Mixed lymphocyte culture reactions generally occur when T-lymphocytes are stimulated by cells that differ across a major histocompatibility antigen (28) . Non-H2 different congenic combinations generally do not result in stimulation (29) . However, an increasing number of exceptions to this generalization have been recognized, and specific loci responsible for mixed lymphocyte cultures have been postulated (30, 31) . One of the exceptions is found in the stimulation of BALB/c (H2d) lymphocytes by DBA/2 (H2d) cells (18, 19) . An M-locus that is not linked to H2 is responsible for this stimulation (31) . Differences at the MLC locus alone generated lymphocyte proliferation but not cytotoxic lymphocytes; it was necessary that both MLC locus and major histocompatibility differences be present and that the target cell differ from the lymphocytes at a major histocompatibility locus in order to be killed. Study of the virus plaque assay, in the present paper, is consistent with these results and further suggests that the functional differences between proliferating lymphocytes and cytotoxic lymphocytes are intrinsic to the lymphocytes themselves and independent of target cells.
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